Lysergic acid diethylamide (LSD) is used in Switzerland in the treatment of patients both in the context of compassionate use and in clinical studies including patients with anxiety associated with life-threatening diseases...more details
This talk will focus on Psychedelic Integration in a clinical setting...more details
While psychoactive drugs such as ketamine and psilocybin have been researched extensively in the past decades, scientific interest in ayahuasca has just started to grow, due to its potential therapeutic benefits....more details
Do psilocybin, LSD and MDMA finally gain medical significance? Dr. Henrik Jungaberle will provide data and concepts that support changes in common misrepresentations about psychedelic states, therapies and their benefit-risk ratio.more details
With your ticket you will have access to the whole conference - with keynotes, panels, round tables, posters and daylight social events. We will ask for a small extra fee for the Friday evening social program. The pre-conference workshops have to be booked separately and each workshop needs an individual ticket. By clicking on "Book now" below you also have the option to buy your workshop tickets.
*Reduced fees apply to students, cooperation partners as well as unemployed and retired individuals who have a monthly net income below 840,- €. Proof of status will be required.
until 14 April 2019
after 14 April 2019